Qdata Prostate Most cancers is Verana Well being’s first disease-specific information module for urology to assist inform analysis for prostate most cancers care
SAN FRANCISCO, Could 12, 2022 /PRNewswire/ — Verana Health®—a digital well being firm elevating high quality in real-world information—in the present day introduced the launch of Urology Qdata™. Urology Qdata for all times sciences corporations will likely be featured at this 12 months’s American Urological Affiliation (AUA) annual assembly alongside Verana Well being’s options for urologists, together with Verana Trial Connect for physicians all for collaborating in medical trials. The annual assembly is happening in New Orleans, Friday, Could 13 to Monday, Could 16.
Urology Qdata contains high quality, disease-specific, de-identified datasets to assist energy urologic analysis and form therapeutic methods. The info stems from Verana Well being’s unique partnership with the AUA to curate, de-identify, and analyze digital well being file (EHR) information from the AUA High quality Registry (AQUA), which incorporates 8 years of longitudinal information from greater than 2,100 healthcare suppliers and practically 10 million sufferers. Verana Well being transforms information from this community of urologists into high quality real-world information (RWD) by its VeraQ™ inhabitants well being information engine. VeraQ makes use of clinician-led synthetic intelligence (AI) approaches, similar to machine studying (ML) and pure language processing (NLP), to deliver which means to structured and unstructured information at scale.
Qdata™ Prostate Most cancers, the primary urology module to launch, is a high-quality, real-world dataset comprising an in depth cohort of sufferers with prostate most cancers. It’s reflective of the affected person journey, which is gleaned from urologists’ de-identified EHR information and linked with claims information for greater than 100,000 sufferers. Following the discharge of Qdata Prostate Most cancers, Verana Well being expects to launch further Urology Qdata modules for urologic ailments together with non-muscle invasive bladder most cancers (NMIBC), overactive bladder, and benign prostatic hyperplasia (BPH).
“Prostate most cancers is the second-most frequent sort of most cancers in males and leads to the deaths of roughly 29,000 Individuals every year,” mentioned Michael T. Sheppard, CPA, CAE, American Urological Affiliation CEO and Verana Well being board member. “Early detection is vital for enhancing the prognosis and lowering the mortality of sufferers with prostate most cancers. Qdata Prostate Most cancers may assist inform earlier illness detection and information higher danger stratification for sufferers with organ-confined prostate most cancers, serving to to drive prostate most cancers analysis—and in the end care—ahead.”
Prostate most cancers happens when a tumor kinds in a person’s prostate, a gland beneath the bladder that produces seminal fluid, normally within the mid-to-late stage of life. A mixture of genetic components, together with inherited and bought mutations, and environmental components, similar to food regimen, contribute to the illness. Organ-confined prostate most cancers is localized to the prostate and has not unfold to different components of the physique. Early detection—usually by urologic care—will help scale back the probability of the illness progressing into metastatic prostate most cancers, the place the illness has unfold past the prostate.
“Major measures used to establish prostate most cancers severity and development, similar to Prostate-Particular Antigen (PSA) ranges and Gleason Scores, are often documented in free-form doctor notes inside urologists’ EHRs, presenting challenges for researchers and clinicians in accessing this very important data in a structured, standardized method,” mentioned Jennifer Bepple, MD, board-certified urologist and Verana Well being medical advisor. “Qdata Prostate Most cancers applies physician-guided algorithms to extract vital data from unstructured information, giving researchers unprecedented insights into the journey of sufferers with prostate most cancers, which may assist inform the usual of take care of sufferers.”
Qdata Prostate Most cancers offers RWE researchers distinctive perception into prostate most cancers illness development by opening up entry to major measures. Moreover, it offers an earlier view into the prostate most cancers journey by providing a greater understanding of remedy selections when the illness is organ confined. To information this, the curated information module contains key variables, similar to PSA degree, Gleason rating, TNM (tumor, node, metastasis) staging, lively surveillance standing, testosterone degree, and extra.
“With Qdata Prostate Most cancers, life sciences corporations acquire a priceless supply of real-world proof into the prostate most cancers journey that may speed up numerous phases of therapeutic growth, together with comparative effectiveness analysis, medical trial website choice, and post-approval proof era,” mentioned Sujay Jadhav, CEO of Verana Well being. “Sufferers with prostate most cancers profit when researchers develop a greater understanding of remedy selections, patterns, and outcomes—all through the affected person journey—and we hope that Qdata Prostate Most cancers helps to advance insights to enhance the standard of care.”
Verana Well being on the 2022 American Urological Affiliation Annual Assembly
Verana Well being will likely be exhibiting at AUA 2022 (Sales space #2529), selling Qdata Prostate Most cancers and showcasing its Verana Trial Join platform, which is on the market to AQUA Registry individuals. Verana Trial Join helps registry-powered medical trials for investigators who conduct analysis at trial websites. Moreover, the know-how helps physicians who wish to refer their sufferers to trials.
Shrujal Baxi, MD, Verana Well being senior vp of medical and scientific options, will ship in-booth shows on AQUA information at 12 p.m. CT every day from Could 13 to fifteen. Moreover, Kari Goodman, PhD, Verana Well being medical trials product supervisor, will ship shows on Verana Well being’s medical trial choices at 12:15 p.m. CT on the identical dates.
Dr. Baxi will even be a part of the AUA leaders at an AQUA Registry Forum and breakfast from 8:00 a.m. to 10:00 a.m. CT within the Rivergate Room on Friday, Could 13. The discussion board will present an summary of the AQUA Registry and the way it can profit urologists, their practices, and their sufferers.
The next two analysis abstracts, utilizing AQUA Registry information, will even be offered in the course of the assembly:
To study extra about Qdata Urology, or to fulfill with Verana Well being at AUA 2022, click here.
About Verana Well being
Verana Well being® is a digital well being firm elevating high quality in real-world information. Verana Well being operates an unique real-world information community of greater than 20,000 healthcare suppliers (HCPs) and about 90 million de-identified sufferers, stemming from its strategic information partnerships with the American Academy of Ophthalmology®, American Academy of Neurology®, and American Urological Affiliation. Utilizing its clinician-informed and synthetic intelligence-enhanced VeraQ™ inhabitants well being information engine, Verana Well being transforms structured and unstructured healthcare information into curated, disease-specific information modules, Qdata™. Verana Well being’s Qdata helps energy analytics options and software-as-a-service merchandise for real-world proof era, medical trials enablement, HCP high quality reporting, and medical registry information administration. Verana Well being’s high quality information and insights assist drive progress in drugs to reinforce the standard of care and high quality of life for sufferers. For extra data, go to www.veranahealth.com.
Media contact:
Megan Moriarty
Amendola Communications
913.515.7530
[email protected]
SOURCE Verana Well being
